FDA Approves Allergan's Cell-based Assay for Botox

As other regulatory agencies worldwide approve the assay, Allergan estimates that the use of animal-based testing for Botox products could be reduced by up to 95 percent or more during the next three years.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.